The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > AtheroGenics, Inc.

AtheroGenics, Inc.
Nasdaq: AGIX
Change
symbol:
     
 PROFILE
AtheroGenics does a bust up job on clogged arteries. The development-stage firm targets such chronic inflammatory diseases as atherosclerosis (clogging of the arteries), asthma, and rheumatoid arthritis by preventing the production of inflammatory proteins. With partner Schering-Plough it is developing lead drug candidate AGI-1067, which may treat restenosis, the reclosure of arteries after angioplasty. AtheroGenics has also developed a blood test to identify a specific marker for atherosclerosis and has identified a compound that may treat organ transplant rejection. The firm's investors include William Blair & Company, Alliance Technology Ventures, and an affiliate of Credit Suisse First Boston.

 COMPETITION
GlaxoSmithKline plc (GSK)
Novartis AG (NVS)
Tanox, Inc. (TNOX)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 8.20
1-Yr. Sales Growth: 530.8%
Employees: 70
Revenue per employee: $117,142.86

 KEY PEOPLE
• Russell M. Medford
    CEO
• Mark P. Colonnese
    CFO

 CONTACT INFO
8995 Westside Pkwy.
Alpharetta, GA 30004
US
Phone: 678-336-2500
Fax: 678-336-2501
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001